Medication-induced constipation affects up to 60% of opioid users and can lead to treatment discontinuation. This guide explains how to prevent and treat it with targeted, evidence-based strategies-beyond fiber and water.
Peripheral artery disease (PAD) causes leg pain and poor circulation due to narrowed arteries. Learn the real symptoms, how it's diagnosed with a simple ABI test, and what treatments actually work-from walking to medications to surgery.
When multiple companies make the same generic drug, prices crash. But as fewer manufacturers enter the market, prices rise - putting patients at risk. Here’s how competition keeps drugs affordable.
Biosimilars work just as well as original biologic drugs, with decades of real-world data confirming comparable safety and effectiveness. They offer major cost savings without compromising outcomes.
Mirtazapine commonly causes weight gain due to increased appetite and metabolic changes. Learn how much weight people gain, why it happens, and how to manage it without stopping treatment.
The FDA issued over 15 major drug safety alerts in 2025, including life-changing updates to opioid prescriptions, MRI requirements for Alzheimer’s drugs, and weight loss warnings for ADHD meds. Here’s what you need to know and what to do next.
Recent FDA drug safety alerts in 2025 revealed hidden risks in opioids, ADHD meds, allergy drugs, and Alzheimer’s treatments. Learn what changed, what you should do, and how to stay safe.
Targeted therapy uses tumor genetics to attack cancer with precision, offering better outcomes and fewer side effects than chemotherapy. But access, cost, and limited targets remain major barriers.
Manufacturer reporting is a legal obligation for companies selling products in the U.S. This article breaks down what medical device, consumer product, and auto manufacturers must report, when, and how - with real data from FDA, CPSC, and NHTSA.